FibroBiologics Inc. (NASDAQ: FBLG)
$5.32
+0.3150 ( +6.30% ) 132.5K
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Market Data
Open
$5.32
Previous close
$5.00
Volume
132.5K
Market cap
$189.67M
Day range
$4.93 - $5.42
52 week range
$3.90 - $55.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Feb 06, 2024 |
8-k | 8K-related | 16 | Feb 02, 2024 |